# Treating Smokers With Mental Illness

> **NCT03822416** · PHASE2 · COMPLETED · sponsor: **University of Minnesota** · enrollment: 38 (actual)

## Conditions studied

- Smoking Cessation
- Cigarette Smoking
- Schizophrenia
- Psychotic Disorders
- Major Depressive Disorder
- Bipolar Disorder I
- Bipolar II Disorder
- Mental Illness

## Interventions

- **DRUG:** Nicotine patch
- **DRUG:** Nicotine lozenge
- **BEHAVIORAL:** Therapy
- **OTHER:** Information

## Key facts

- **NCT ID:** NCT03822416
- **Lead sponsor:** University of Minnesota
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-03-01
- **Primary completion:** 2020-05-04
- **Final completion:** 2020-05-04
- **Target enrollment:** 38 (ACTUAL)
- **Last updated:** 2021-05-25

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03822416

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03822416, "Treating Smokers With Mental Illness". Retrieved via AI Analytics 2026-07-17 from https://api.ai-analytics.org/clinical/NCT03822416. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*